Indications for Antinuclear Antibody Testing Mª José Amengual MD / Begoña Marí MD LABORATORY SERVICE. Corporació Sanitària Parc Taulí
The authors review the recent literature on antinuclear antibody testing with the aim of providing information about its clinical usefulness in the diagnosis and prognosis of systemic autoimmune diseases.
The Big Five: Cardiovascular Risk Factors Joan Solà Aznar MD INTERNAL MEDICINE SERVICE. Corporació Sanitària Parc Taulí
An epidemiological review of the contribution of the main cardiovascular risk factors (smoking, hypertension, dyslipemia, diabetes, and obesity/metabolic syndrome) to cardiovascular morbimortality is provided, emphasizing the importance of the aggregation of risk factors and the need for an integrated approach in improving the prognosis of these patients.
The exclusion of the elderly from clinical trials:Proposal of a Charter for clinical research in the elderly Joaquim Oristrell MD / Xavier Pla MD INTERNAL MEDICINE SERVICE. Corporació Sanitària Parc Taulí
The elderly seldom participate in clinical trials. This affects the external validity of many trials and makes the clinical management of an increasingly aging population with multiple disease more difficult. The EU- funded PREDICT study was recently concluded with the elaboration of a Charter to promote research in the elderly.
Update on Hodgkin's Lymphoma Elena Rámila MD HEMATOLOGY SERVICE. Corporació Sanitària Parc Taulí
The authors review the etiopathogenesis, standard treatment approaches and prognosis of Hodgkin's lymphoma. In addition, the experience of the Hematology Service of CSPT in the management of this lymphoma is presented.
